COLD-ADAPTED LIVE ATTENUATED VIRULENCE FACTOR-REMOVED VACCINE SUITABLE FOR MUCOSAL DELIVERY
FIELD: biotechnology.SUBSTANCE: there are presented compositions and methods for preparing a live attenuated influenza vaccine suitable for nasal administration. This vaccine employs a cold-adapted influenza virus which does not contain a virulence factor, containing mutations providing the ability...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; rus |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!